Palmitoylethanolamide (PEA), a naturally occurring fatty acid, is increasingly catching the attention of the dietary supplement sector owing to its potential health advantages. Research has ...
Under the collaboration, SciSparc and Clearmind are researching combination therapies that integrate psychedelic molecules with the N-acylethanolamines family, including Palmitoylethanolamide.
SciSparc teams up with Clearmind Medicine on innovative therapies for binge behaviors and secures FDA approval for a Tourette Syndrome Phase 2b trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback